Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
43 studies found for:    Open Studies | "Helicobacter Infections"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Helicobacter Infections"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Comparison of 7-Day and 14-Day Bismuth Based Quadruple Therapy for Secondary Helicobacter Pylori Eradication
Condition: Helicobacter Infection
Interventions: Drug: pantoprazole;   Drug: bismuth;   Drug: metronidazole;   Drug: tetracycline
2 Unknown  Standard Triple Therapy vs Sequential Therapy in Treatment of H Pylori Infection
Condition: Helicobacter Infection
Interventions: Drug: Standard Triple Therapy;   Drug: Sequential Therapy
3 Recruiting The Efficacy of the 7 Days Tailored Therapy as 2nd Rescue Therapy for Eradication of H. Pylori Infection
Condition: Helicobacter Infection
Interventions: Procedure: H. pylori culture and antimicrobial susceptibility testing;   Drug: 14 days empirical bismuth quadruple therapy (Proton pump inhibitor);   Drug: Metronidazole;   Drug: Tetracycline;   Drug: tripotassium dicitrate bismuthate;   Drug: 7 days tailored therapy Proton Pump Inhibitor;   Drug: Moxifloxacin;   Drug: Amoxicillin
4 Not yet recruiting Endofaster Test for Helicobacter Pylori Detection in Patients on Proton Pump Inhibitor Therapy
Condition: Helicobacter Infections
Interventions: Procedure: Gastroscopy;   Device: EndoFaster test;   Other: Clo test;   Other: Faecal Helicobacter pylori antigen
5 Recruiting Efficacy and Safety of Basic Triple Therapy Including Ilaprazole on the First Line Eradication Treatment of H.Pylori
Condition: Helicobacter Infections
Interventions: Drug: Noltec tab. 10mg;   Drug: Chongkundang Amoxicillin Cap. 500mg;   Drug: Cravit Tab. 500mg
6 Unknown  Second Line Therapy for the Cure of Helicobacter Pylori (H. Pylori) Infection
Conditions: Helicobacter Infections;   Gastritis;   Gastric Ulcer;   Duodenal Ulcer
Intervention: Drug: rabeprazole, amoxicillin, clarithromycin, metronidazole
7 Unknown  Treating H. Pylori in Parkinson's Patients With Motor Fluctuations
Conditions: Parkinson's Disease;   Helicobacter Infections;   Motor Fluctuations
Interventions: Drug: clartihromycin, amoxicillin, and omeprazole;   Drug: placebo
8 Unknown  Tailored Treatment of H. Pylori Infection Based Polymorphisms of CYP2C19 and 23S rRNA of H. Pylori
Conditions: Helicobacter Infections;   Gastritis;   Gastric Ulcer;   Duodenal Ulcer
Intervention: Drug: Lansoprazole, clarithromycin, amoxicillin
9 Unknown  Immediate Detection of Helicobacter Infection With a New Electrochemical System.
Condition: H. Pylori Infection
Interventions: Device: Electrochemical H. pylori detection method;   Device: IHC;   Device: C13-urea breath test;   Device: HUT
10 Recruiting Helicobacter Pylori Eradication Study in Parkinson's Disease
Conditions: Parkinson's Disease;   Helicobacter Pylori Infection
Interventions: Drug: Helicobacter pylori eradication therapy;   Drug: Placebo
11 Not yet recruiting The Impact of Addition of Curcumin for 10 Days Triple Therapy, on the Eradication Rate of Helicobacter Pylori Infection
Condition: Positivity for Helicobacter Pylori
Intervention: Dietary Supplement: Curcumin
12 Unknown  An Investigation of the Association Between Helicobacter Pylori Infection and Abdominal Pain in Cystic Fibrosis Patients
Conditions: Cystic Fibrosis;   Abdominal Pain;   Helicobacter Pylori Infection
Intervention:
13 Unknown  Efficacy and Safety of InSan Bamboo Salt on Improvement of Helicobacter Pylori Infection
Condition: Helicobacter Pylori Infection
Interventions: Dietary Supplement: InSan Bamboo Salt;   Dietary Supplement: Placebo
14 Recruiting Community-based Helicobacter Pylori Eradication
Condition: Helicobacter Pylori Infection
Intervention: Drug: Helicobacter pylori eradication
15 Recruiting Efficacy of 10-day Concomitant Regimen Versus High Dose Dual Therapy in Anti-Helicobacter Pylori Rescue Therapy
Condition: Helicobacter Pylori Infection
Interventions: Drug: high dose dual therapy;   Drug: concomitant therapy
16 Not yet recruiting The Diagnostic Validity of the Urea Breath Test
Condition: Helicobacter Pylori Infection
Intervention: Drug: Citric acid
17 Recruiting Comparison of 12-day Reverse Hybrid Therapy and 12-day Standard Triple Therapy for Helicobacter Pylori Infection
Condition: Helicobacter Pylori Infection
Interventions: Drug: Reverse hybrid therapy;   Drug: Standard triple therapy
18 Not yet recruiting Difference in H. Pylori Infection Rate of EGC Patients Before and After Endoscopic Resection
Condition: Early Gastric Cancer
Intervention:
19 Recruiting Helicobacter Pylori Eradication for Gastric Cancer Prevention in the General Population
Conditions: Gastric Cancer;   Helicobacter Pylori Infection
Intervention: Drug: 10-day bismuth-based quadruple therapy
20 Recruiting Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer Mortality
Conditions: Helicobacter Pylori Infections;   Atrophic Gastritis;   Gastric Cancer
Intervention: Drug: Triple therapy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years